--------------------------------------------------------------------------------
Fedora Update Notification
FEDORA-2018-dda1a39ccb
2018-06-28 14:06:06.103055
--------------------------------------------------------------------------------

Name        : ugene
Product     : Fedora 28
Version     : 1.30.0
Release     : 2.fc28
URL         : http://ugene.unipro.ru
Summary     : Integrated bioinformatics toolkit
Description :
Unipro UGENE is a cross-platform visual environment for DNA and protein
sequence analysis. UGENE integrates the most important bioinformatics
computational algorithms and provides an easy-to-use GUI for performing
complex analysis of the genomic data. One of the main features of UGENE
is a designer for custom bioinformatics workflows.

--------------------------------------------------------------------------------
Update Information:

The new version is majorly a bug-fix release.
--------------------------------------------------------------------------------
ChangeLog:

* Thu Jun 14 2018 Yuliya Algaer <[email protected]> - 1.30.0-2
- New upstream release
--------------------------------------------------------------------------------

This update can be installed with the "dnf" update program. Use
su -c 'dnf upgrade --advisory FEDORA-2018-dda1a39ccb' at the command
line. For more information, refer to the dnf documentation available at
http://dnf.readthedocs.io/en/latest/command_ref.html#upgrade-command-label

All packages are signed with the Fedora Project GPG key. More details on the
GPG keys used by the Fedora Project can be found at
https://fedoraproject.org/keys
--------------------------------------------------------------------------------
_______________________________________________
package-announce mailing list -- [email protected]
To unsubscribe send an email to [email protected]
Fedora Code of Conduct: https://getfedora.org/code-of-conduct.html
List Guidelines: https://fedoraproject.org/wiki/Mailing_list_guidelines
List Archives: 
https://lists.fedoraproject.org/archives/list/[email protected]/message/5N4BDPRRSFQQNRUWYB4KPGUO4LXWGR3U/

Reply via email to